Anandamide inhibits the DOI-induced head-twitch response in mice

Psychopharmacology

Volumn 171, Issue 4, 2004, Pages 382-389

  Egashira, Nobuaki ^a   Mishima, Kenichi ^a   Uchida, Tomoko ^a   Hasebe, Nobuyoshi ^a   Nagai, Hiroshi ^b   Mizuki, Ai ^a   Iwasaki, Katsunori ^a   Ishii, Hisanori ^b   Nishimura, Ryoji ^b   Shoyama, Yukihiro ^c   Fujiwara, Michihiro ^a  

^a FUKUOKA UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

9 Tetrahydrocannabinol; 5 HT; Anandamide; Cannabinoid receptor; CB; Cyclooxygenase inhibitor; Head twitch response; Receptor; Vanilloid receptor; VR

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ACETYLSALICYLIC ACID; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID 1 RECEPTOR; INDOMETACIN; PROSTAGLANDIN SYNTHASE INHIBITOR; RIMONABANT; SEROTONIN 2A RECEPTOR; TETRAHYDROCANNABINOL;

ANIMAL EXPERIMENT; ARTICLE; DRUG EFFECT; DRUG MECHANISM; HEAD TWITCH; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMPHETAMINES; ANIMALS; ARACHIDONIC ACIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HEAD MOVEMENTS; MALE; MICE; POLYUNSATURATED ALKAMIDES;

EID: 10744232611     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1611-y     Document Type: Article

References (39)

1. Adams IB, Compton DR, Martin BR (1998) Assessment of anandamide interaction with the cannabinoid brain receptor: SR141716A antagonism studies in mice and autoradiographic analysis of receptor binding in rat brain. J Pharmacol Exp Ther 284:1209-1217
2. Al-Hayani A, Wease KN, Ross RA, Pertwee RG, Davies SN (2001) The endogenous cannabinoid anandamide activates vanilloid receptors in the rat hippocampal slice. Neuropharmacology 41:1000-1005
3. Al-Khatib IMH, Dökmeci I, Fujiwara M (1995) Differential role of nucleus accumbens and caudate-putamen in mediating the effect of nomifensine and methamphetamine on ambulation and rearing of rats in the open-field test. Jpn J Pharmacol 67:69-77
4. Barnes NM, Sharp T (1999) A review of central 5-HT receptors and their function. Neuropharmacology 38:1083-1152
5. Corne SJ, Pickering RW (1967) A possible correlation between drug-induced hallucinations in man and a behavioral response in mice. Psychopharmacologia 11:65-78
6. 2A receptor-mediated behaviors in mice. Pharmacol Biochem Behav 68:311-317
7. 1 receptor antagonist SR141716A in naive mice. J Neural Transm 107:931-945
8. 2 receptors? Pharmacol Biochem Behav 36:901-906
9. Deutsch DG, Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46:791-796
10. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258:1946-1949
11. Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21:521-528
12. Di Marzo V, Bisogno T, De Petrocellis L (2001a) Anandamide: some like it hot. Trends Pharmacol Sci 22:346-349
13. Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ (2001b) Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur J Pharmacol 420:123-131
14. 9-tetrahydrocannabinol- induced impairment of spatial memory. Eur J Pharmacol 445:221-229
15. Felder CC, Briley EM, Axelrod J, Simpson JT, Mackie K, Devane WA (1993) Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc Natl Acad Sci USA 90:7656-7660
16. Felder CC, Nielsen A, Briley EM, Palkovits M, Priller J, Axelrod J, Nguyen DN, Richardson JM, Riggin RM, Koppel GA, Paul SM, Becker GW (1996) Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat. FEBS Lett 393:231-235
17. Fride R, Mechoulam R (1993) Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. Eur J Pharmacol 231:313-314
18. 1 receptors in vivo. J Neurochem 70:417-423
19. 2 agonists or antagonists? Neuropsychopharmacology 3:509-517
20. Herkenham M, Lynn AB, Johnson MR, Melvin LS, de Costa BR, Rice KC (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J Neurosci 11:563-583
21. Hunter SA, Burstein SH (1997) Receptor mediation in cannabinoid stimulated arachidonic acid mobilization and anandamide synthesis. Life Sci 60:1563-1573
22. 9-THC and other cannabinoids. Pharmacol Biochem Behav 71:155-162
23. 2A antagonist with a favorable CNS safety profile. J Pharmacol Exp Ther 277:968-981
24. Kimura T, Ohta T, Watanabe K, Yoshimura H, Yamamoto I (1998) Anandamide, an endogenous cannabinoid receptor ligand, also interacts with 5-hydroxytryptamine (5-HT) receptor. Biol Pharm Bull 21:224-226
25. 2 receptors. Psychopharmacology 112:S40-S54
26. 9-Tetrahydrocannabinol impairs spatial memory through a cannabinoid receptor mechanism. Psychopharmacology 126:125-131
27. 3H]MDL 100,907. Naunyn-Schmiedeberg's Arch Pharmacol 356:446-454
28. 9-tetrahydrocannabinol or anandamide. Psychopharmacology 140:11-19
29. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990) Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346:561-564
30. 9-tetrahydrocannabinol in rats. Jpn J Pharmacol 87:297-308
31. Munro S, Thomas KL, Abu-Shaar M (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365:61-65
32. Pazos A, Cortes R, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. II. Serotonin-2 receptors. Brain Res 346:231-249
33. Reichman M, Nen W, Hokin LE (1988) Delta9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices. Mol Pharmacol 34:823-828
34. Smith PB, Compton DR, Welch SP, Razdan RK, Mechoulam R, Martin BR (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J Pharmacol Exp Ther 270:219-227
35. 9-tetrahydrocannabinol and anandamide antinociception in non-arthritic and arthritic rats. Pharmacol Biochem Behav 60:183-191
36. Tognetto M, Amadesi S, Harrison S, Creminon C, Trevisani M, Carreras M, Matera M, Geppetti P, Blanchi A (2001) Anandamide excites central terminals of dorsal root ganglion neurons via vanilloid receptor-1 activation. J Neurosci 21:1104-1109
37. Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R (1993) Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. J Neurochem 61:352-355
38. Willoughby KA, Moore SF, Martin BR, Ellis EF (1997) The biodisposition and metabolism of anandamide in mice. J Pharmacol Exp Ther 282:243-247
39. Yamaguchi T, Shoyama Y, Watanabe S, Yamamoto T (2001) Behavioral suppression induced by cannabinoids is due to activation of the arachidonic acid cascade in rats. Brain Res 889:149-154